Managing LDL-C to Reduce Cardiovascular Disease Risk: Defining Best Clinical Practice

April 22, 2019

In this program, an expert faculty will discuss the evidence and recommendations for managing LDL-C in patients with ASCVD, familial hypercholesterolemia (FH), diabetes, and those at increased cardiovascular risk without ASCVD.

2.00 Credits

CROSSROADS OF CARE: Facing the Challenges of Heart Failure and Diabetes

April 01, 2019

In this symposium, Dr. James Januzzi and Dr. Mikhail Kosiborod will explain the intertwined relationship between diabetes and HF, and interpret safety and effi cacy data, focusing on HF-related outcomes, from studies with diabetes therapies.

1.00 Credits

Hyperkalemia and Heart Failure: Recognizing Risks and Exploring Strategies for Improving Outcomes

February 24, 2019

In this program, Dr. Paul Hauptman and Dr. Javed Butler will 1) describe the relationship between RAAS inhibitors, hyperkalemia, and cardiovascular risk, 2) identify goals and treatments for acute, intermediate, and chronic management, and 3) discuss the clinical profi les of, and clinical settings for the use of, new potassium binders.

CME 1.00 Credits

Narcolepsy in Children: Insights into Diagnosis and Strategies to Improve Patient Care

December 30, 2018

In this program, pediatric sleep disorder experts Dr. Kiran Maski and Dr. Merrill Wise will describe strategies to overcome barriers in diagnosing narcolepsy in children, and explain best practices in treatment including emerging evidence with pharmacologic therapy.

1.00 Credits

Fine-tuning the Management of Narcolepsy and Excessive Daytime Sleepiness in Obstructive Sleep Apnea

August 23, 2018

This program will focus on the diagnosis and treatment of narcolepsy and EDS in OSA. Format will consist of state-of-the-art lectures and debates chaired by Michael Thorpy, MD with faculty Michael Sateia, MD; Thomas Scammell, MD,Kingman Strohl, MD; Phyllis Zee, MD, PhD

2.00 Credits

LDL-Cholesterol Lowering and Atherosclerotic Cardiovascular Disease Risk Reduction: Exploring the Evidence With Non-Statin Therapy

June 17, 2018

n this program, lipid experts will present, in state-of-the-art lectures and in 'realworld' interactive cases, optimal strategies and provide 'take-home' messages for reducing risk in patients with elevated LDL-C.

CME 2.00 Credits

Improving Outcomes in Patients with Elevated LDL-Cholesterol: A Case-Based Series

January 01, 2018

An informative expert series of lectures including cases with the goal of improving outcomes in patients with elevated LDL-cholesterol

No Credit Available